Allena Pharmaceuticals is developing and commercializing non-systemic protein therapeutics to treat metabolic and orphan diseases, with a particular focus on nephrologic and urologic conditions.

Spotlight

01.08.16 Allena Pharmaceuticals to Present at the 34th Annual J.P. Morgan Healthcare Conference

12.09.15 Allena Pharmaceuticals Raises $53 Million in Series C Financing